Sphingosine-1-Phosphate Catabolizing Enzymes Predict Better Prognosis in Triple-Negative Breast Cancer Patients and Correlates With Tumor-Infiltrating Immune Cells

Background: Triple-negative breast cancer (TNBC) is associated with a poor prognosis. Sphingosine-1-phosphate (S1P), a potent sphingolipid metabolite, has been implicated in many processes that are important for breast cancer (BC). S1P signaling regulates tumorigenesis, and response to chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Nema, Rajeev, Kumar, Ashok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255376/
https://www.ncbi.nlm.nih.gov/pubmed/34235182
http://dx.doi.org/10.3389/fmolb.2021.697922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255376/
https://www.ncbi.nlm.nih.gov/pubmed/34235182
http://dx.doi.org/10.3389/fmolb.2021.697922

Ejemplares similares